These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 803254)

  • 61. Pharmacological disposition of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea in mice.
    Rahman A; Luc PV; Schein PS; Woolley PV
    Cancer Res; 1984 Jan; 44(1):149-53. PubMed ID: 6690033
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Irreversible enzyme inhibitors. 178. Active-site-directed irreversible inhibitors of dihydrofolate reductase derived from 1-(4-benzyloxy-3-chlorophenyl)-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine with a terminal sulfonyl fluoride.
    Baker BR; Ashton WT
    J Med Chem; 1970 Nov; 13(6):1161-5. PubMed ID: 5479857
    [No Abstract]   [Full Text] [Related]  

  • 63. Irreversible enzyme inhibitors. CX. Candidate irreversible inhibitors of dihydrofolic reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine. IV.
    Baker BR; Lourens GJ
    J Med Chem; 1968 Jan; 11(1):34-7. PubMed ID: 5237172
    [No Abstract]   [Full Text] [Related]  

  • 64. In vivo pharmacokinetics of triazinate in L-1210 and W-256 cells.
    Townsend JG; Jain RK; Cashmore AR
    J Pharm Sci; 1982 Oct; 71(10):1102-5. PubMed ID: 7143204
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [S35 lipoic acid distribution and its effect on pyruvate dehydrogenase activity in rats with Walker carcinoma].
    Karpov LM; Dvuzhil'naia ED; Savvov VI; Phan Van Thuy
    Vopr Onkol; 1977; 23(10):87-90. PubMed ID: 339543
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Irreversible enzyme inhibitors. CLXXVII. Active-site-directed irreversible inhibitors of dihydrofolate reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(phenylalkylphenyl)-s-triazines. II.
    Baker BR; Vermeulen NM
    J Med Chem; 1970 Nov; 13(6):1154-60. PubMed ID: 5479856
    [No Abstract]   [Full Text] [Related]  

  • 67. Regeneration of tetrahydrohomofolate in cells. Possible basis for antitumor activity of homofolates.
    Mishra LC; Parmar AS; Mead JA
    Biochem Pharmacol; 1974 Jul; 23(13):1827-34. PubMed ID: 4458665
    [No Abstract]   [Full Text] [Related]  

  • 68. Tissue distributions of 97Ru and 103Ru in subcutaneous tumor of rodents.
    Tanabe M; Yamamoto G
    Acta Med Okayama; 1975 Dec; 29(6):431-6. PubMed ID: 132843
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Irreversible enzyme inhibitors. CIX. Candidate irreversible inhibitors of dihydrofolic reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine. 3.
    Baker BR; Lourens GJ
    J Med Chem; 1968 Jan; 11(1):26-33. PubMed ID: 5237171
    [No Abstract]   [Full Text] [Related]  

  • 70. Preclinical studies with triazinate (NSC-139105), an antifolate drug, in beagle dogs and rhesus monkeys.
    Gralla EJ; Coleman GL; Osbaldiston W; Sawicki WL; Jonas RM; Bertino JR
    Cancer Chemother Rep; 1975; 59(3):523-30. PubMed ID: 812604
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Preclinical biochemical pharmacology and toxicology of piritrexim, a lipophilic inhibitor of dihydrofolate reductase.
    Sigel CW; Macklin AW; Woolley JL; Johnson NW; Collier MA; Blum MR; Clendeninn NJ; Everitt BJ; Grebe G; Mackars A
    NCI Monogr; 1987; (5):111-20. PubMed ID: 3431588
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Irreversible enzyme inhibitors. 197. Water-soluble reversible inhibitors of dihydrofolate reductase with potent antitumor activity derived from 4, 6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine.
    Baker BR; Ashton WT
    J Med Chem; 1973 Mar; 16(3):209-14. PubMed ID: 4733101
    [No Abstract]   [Full Text] [Related]  

  • 73. Irreversible enzyme inhibitors. CXII. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine substituted with a terminal sulfonyl fluoride. II.
    Baker BR; Lourens GJ
    J Med Chem; 1968 Jan; 11(1):38-41. PubMed ID: 5237173
    [No Abstract]   [Full Text] [Related]  

  • 74. Distribution and excretion in the rat and monkey of [82Br] bromocriptine.
    Markey SP; Colburn RW; Kopin IJ; Aamodt RL
    J Pharmacol Exp Ther; 1979 Oct; 211(1):31-5. PubMed ID: 114621
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Irreversible enzyme inhibitors. 196. Active-site-directed irreversible inhibitors of dihydrofolate reductase derived from 1-(4-benzyloxy-3-chlorophenyl)-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine and bearing a terminal phenyl sulfonate group.
    Baker BR; Ashton WT
    J Med Chem; 1972 Sep; 15(9):945-7. PubMed ID: 5051014
    [No Abstract]   [Full Text] [Related]  

  • 76. Pharmacologic disposition of DL-alanosine in mice, rats, dogs, and monkeys.
    Kelley JM; Adamson RH; Cooney DA; Jayaram HN; Anandaraj S
    Cancer Treat Rep; 1977 Nov; 61(8):1471-84. PubMed ID: 411570
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pepstatin, an inhibitor of leukokinin formation and ascitic fluid accumulation.
    Greenbaum LM; Grebow P; Johnston M; Prakash A; Semente G
    Cancer Res; 1975 Mar; 35(3):706-10. PubMed ID: 46779
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Irreversible enzyme inhibitors. CXVII. Hydrophobic bonding to dihydrofolic reductase. XI. Comparison of the enzyme from Walker 256, rat liver, and L1210 mouse leukemia.
    Baker BR
    J Med Chem; 1968 May; 11(3):483-6. PubMed ID: 5241406
    [No Abstract]   [Full Text] [Related]  

  • 79. Distribution of [3H]cytosine arabinoside and its products in mice, dogs, and monkeys and effect of tetrahydrouridine.
    Dareer SM; Mulligan LT; White V; Tillery K; Mellett LB; Hill DL
    Cancer Treat Rep; 1977; 61(3):395-407. PubMed ID: 406044
    [No Abstract]   [Full Text] [Related]  

  • 80. [Pharmacokinetics of ftorafur-2-14C in rats with Walker carcinosarcoma].
    Kozhukhov AN; Meĭren DV; Gilev AP
    Biull Eksp Biol Med; 1977 Jun; 83(6):734-6. PubMed ID: 328081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.